Glomerular-Tubulointerstitial Disorders

Tubulointerstitial diseases are clinically heterogeneous disorders that share similar features of tubular and interstitial injury. In severe and prolonged cases, the entire kidney may become involved, with glomerular dysfunction and even renal failure. The primary categories of tubulointerstitial disease are

  • Acute tubular necrosis
  • Acute or chronic tubulointerstitial nephritis

Contrast nephropathy is acute tubular necrosis caused by an iodinated radiocontrast agent.

 

Analgesic nephropathy is a type of chronic interstitial nephritis, and reflux nephropathy and myeloma kidney can involve chronic tubulointerstitial nephritis.

Tubulointerstitial disorders can also result from metabolic disturbances and exposure to toxins.

Pathophysiology

The kidneys are exposed to unusually high concentrations of toxins. The kidneys have the highest blood supply of all tissues (about 1.25 L/min or 25% of cardiac output), and unbound solutes leave the circulation via glomerular filtration at ≥ 100 mL/min; as a result, toxic agents are delivered at a rate 50 times that of other tissues and in much higher concentrations. When urine is concentrated, the luminal surfaces of tubular cells may be exposed to molecule concentrations 300 to 1000 times greater than those of plasma. The fine brush border of proximal tubular cells exposes an enormous surface area. A countercurrent flow mechanism increases ionic concentration of the interstitial fluid of the medulla (and thereby increases urine concentration) up to 4 times the plasma concentration.

In addition, factors can affect cellular vulnerability after exposure to toxins:

  • Tubular transport mechanisms separate drugs from their binding proteins, which normally protect cells from toxicity.
  • Transcellular transport exposes the interior of the cell and its organelles to newly encountered chemicals.
  • Binding sites of some agents (eg, sulfhydryl groups) may facilitate entry but retard exit (eg, heavy metals).
  • Chemical reactions (eg, alkalinization, acidification) may alter transport in either direction.
  • Blockade of transport receptors may alter tissue exposure (eg, diuresis from blockade of adenosine A1 receptors, such as with aminophylline, may decrease exposure).
  • The kidneys have the highest oxygen and glucose consumption per gram of tissue and are therefore vulnerable to toxins affecting cell energy metabolism.

 

Acute tubular necrosis (ATN)

Acute tubular necrosis (ATN) is kidney injury characterized by acute tubular cell injury and dysfunction. Common causes are hypotension or sepsis that causes renal hypoperfusion and nephrotoxic drugs. The condition is asymptomatic unless it causes renal failure. The diagnosis is suspected when azotemia develops after a hypotensive event, severe sepsis, or drug exposure and is distinguished from prerenal azotemia by laboratory testing and response to volume expansion. Treatment is supportive.

Analgesic nephropathy

Analgesic nephropathy is chronic tubulointerstitial nephritis caused by cumulative lifetime use of large amounts (eg, ≥ 2 kg) of certain analgesics. Patients present with kidney injury and usually non-nephrotic proteinuria and bland urinary sediment or sterile pyuria. Hypertension, anemia, and impaired urinary concentration occur as renal insufficiency develops. Papillary necrosis occurs late. Diagnosis is based on a history of analgesic use and results of noncontrast CT. Treatment is stopping the causative analgesic.

 

Contrast nephropathy

Contrast nephropathy is worsening of renal function after IV administration of radiocontrast and is usually temporary. Diagnosis is based on a progressive rise in serum creatinine 24 to 48 h after contrast is given. Treatment is supportive. Volume loading with isotonic saline before and after contrast administration may help in prevention.

Others

  • Heavy Metal Nephropathy
  • Metabolic Nephropathies
  • Myeloma-Related Kidney Disease
  • Tubulointerstitial Nephritis
  • Vesicoureteral Reflux and Reflux Nephropathy
  • Glomerulonephritis
  • Acute Tubular Necrosis
  • Acute Interstitial Nephritis Associated to Drugs
  • Xanthogranulomatous Pyelonephritis
  • Specific Renal Infections
  • Chronic Infectious Tin (Chronic Pyelonephritis)
  • Tin Associated with Systemic Infection
  • Acute Infectious Tubulointerstitial Nephritis
  • Chronic Pyelonephritis
  • Acute Pyelonephritis
  • Glomerulopathy
  • Other Tubular Changes
  • Respiratory Alkalosis

Related Conference of Glomerular-Tubulointerstitial Disorders

October 23-24, 2019

23rd European Nephrology Conference

Rome, Italy
October 24-25, 2019

23rd European Nephrology Conference

Rome, Italy
November 11-12, 2019

15th International Conference on Nephrology and Hypertension

Renaissance Polat Istanbul Hotel | Istanbul , Turkey

November 14-15, 2019

European Congress on Nephrology & Urology

Zagreb, Croatia
November 25-26, 2019

2nd International Conference on Nephrology

Dubai, UAE
April 27-28, 2020

16th World Nephrology Conference

Singapore
April 27-28, 2020

5th World Kidney Congress

Dubai, UAE
May 13-14, 2020

20th World Kidney Congress

Berlin, Germany
June 10-11, 2020

21st Global Nephrologists Annual Meeting

Frankfurt, Germany
November 23-24, 2020

World Congress and Expo on Nephrology

Hanoi, Vietnam
May 24,25,2021

kidneycongress 2021

Istanbul, Turkey

Glomerular-Tubulointerstitial Disorders Conference Speakers

Recommended Sessions

Related Journals

Are you interested in